Literature DB >> 9827459

[Cardiac sympathetic nerve activity in ischemic heart failure].

G Richardt1, F Hartmann, C Slotty, H A Katus.   

Abstract

The prognosis in patients with heart failure, independent of etiology, is determined mainly by the extent of sympatho-adrenergic stimulation. In the development of heart failure sympathetic cardiac stimulation precedes systemic sympatho-adrenergic activation. Increased concentrations of the neurotransmitter norepinephrine can be found in the myocardium. This is a result of both increased release from sympathetic nerves as well as reduced neuronal reuptake. We were able to show that in advanced heart failure these effects are distributed heterogeneously in the heart. It has been shown experimentally that the effects on sympathetic neurotransmission are similar for both ischemia and heart failure. Therefore, these findings could indicate an important role of sympatholytic measures in patients with ischemia induced heart failure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9827459     DOI: 10.1007/s003920050529

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  1 in total

1.  Feasibility of 2-deoxy-2-[18F]fluoro-D-glucose- A85380-PET for imaging of human cardiac nicotinic acetylcholine receptors in vivo.

Authors:  Jan Bucerius; Alexius Y Joe; Jörn Schmaljohann; Daniela Gündisch; Martina Minnerop; Hans-Jürgen Biersack; Ullrich Wüllner; Michael J Reinhardt
Journal:  Clin Res Cardiol       Date:  2006-01-19       Impact factor: 5.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.